Mónica Lombardo

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease

Juan Manuel Figueroa, Mónica Lombardo, Ariel Dogliotti et al. · International Journal of General Medicine · 2021 · 74 citations · Full text

A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine

Juan Dupont, Javier Altclas, Alejandro Lepetic et al. · Vaccine · 2006 · 65 citations

Vaccination, Vaccine Safety, Infectious Disease Prevention +8

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

José Mordoh, M. Betina Pampena, Mariana Aris et al. · Frontiers in Immunology · 2017 · 29 citations · Full text

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults

Karina A. Pasquevich, Lorena M. Coria, Ana Ceballos et al. · Nature Communications · 2023 · 14 citations · Full text

Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease A pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02)

Juan Manuel Figueroa, Mónica Lombardo, Ariel Dogliotti et al. · 2021 · 12 citations · Full text

Cell Culture, Placebo-controlled Trial, Pharmacotherapy +18